Heart Disease

304. Sulphonylureas increase cardiac deaths but are still recommended for use after Metformin in type two diabetics in Scotland.

This article is by kaitiscotland and was first published on 15th February 2018. The original article can be sourced here: diabetesdietblog.com/2018/02/15/sulphonylureas-increase-cardiac-deaths-but-are-still-recommended-for-use-after-metformin-in-type-two-diabetics-in-scotland/ I am most grateful to Emma Baird for permission to re-post on this blog. Background After the cardiovascular issues with rosiglitazone, cardiovascular safety trials had to be conducted for all new anti-hyperglycemic agents. However, […]

304. Sulphonylureas increase cardiac deaths but are still recommended for use after Metformin in type two diabetics in Scotland. Read More »

289. Root Cause Analysis

Background Food safety is a serious business. If a company produces a food item that is subsequently found to have harmed those who consume it, this is very bad news. Customers lose faith and sales are likely to suffer. Even worse, the retailer may terminate the supplier contract, which may mean that the business collapses.

289. Root Cause Analysis Read More »

283. Obsessed with Cholesterol

I have lost count of the number of people I have met who are convinced that they should be concerned about the cholesterol level in their blood. If it is considered to be “too high” then they are at serious risk of suffering from heart disease. Hence action has to be taken that will lower

283. Obsessed with Cholesterol Read More »

282. Antonio C. Martinez II’s Type 2 Diabetes (T2D) Reversal

post282. Antonio C. Martinez II’s Type 2 Diabetes (T2D) Reversal The stories about individuals who successfully reverse T2D successfully just keep coming. Here is another one about Antonio Martinez, with lots of interesting relevant information that provides valuable insight into the changes in his body. I am most grateful to Antonio for permission to post

282. Antonio C. Martinez II’s Type 2 Diabetes (T2D) Reversal Read More »

279. Statins in Women

Most evidence based on studies in men The case for the widespread use of statins is extremely flimsy. The trials that provide the justification have been subject to detailed criticisms (1). In any event most of them were conducted before effective regulatory controls were introduced. As the work has been primarily with men, the case

279. Statins in Women Read More »

Scroll to Top